About 2 years ago a milestone was set in the Belgian Advanced Therapy Medicinal Products (“ATMP”) legislation, enabling progress in the development of new, innovative therapies based upon handling of human cells and tissues for the production of medicines. In this webinar you will discover the most important elements of this law.
About is the speaker
Marc Martens is board member of bio.be and partner of Bird & Bird. He is co-head of Bird & Bird’s International Life Sciences & Healthcare group and head of Bird & Bird’s Regulatory, Public & Administrative Law group in Brussels. His areas of expertise cover issues relating to life-cycle management, clinical trials and data, data exclusivity, marketing, price and reimbursement authorizations, and e-health together with data protection, distribution and advertising issues. He provides advice to biotech companies on issues regarding Advanced Therapy Medicinal Products as well as the legal and bioethical issues relating to research and use of human cells and tissues.